Vinod Nair, Head of Research, Geojit Financial Services, sheds light on the geopolitical scenario amid the ongoing Trump tariff war, along with an outlook for the Q4 results and the Indian stock ...

Indian pharmaceutical stocks tumbled 4.4% on Friday, erasing gains from the previous session, after Trump threatened steep ...

Indian pharmaceutical stocks fell 4.4% on Friday, wiping out gains from the previous session, after U.S. President Donald ...

Billionaire entrepreneur and Cost Plus Drugs co-founder Mark Cuban won't have to raise medicine prices, as Trump’s new ...

Indian shares tumbled after President Donald Trump’s comments that the US is still considering tariffs on pharmaceutical ...

Indian pharmaceutical stocks took a hit as Trump's threat of imposing tariffs on pharma imports spooked investors. Despite ...

India expects minimal price changes for its pharma exports under new US tariffs, as punitive measures haven’t hit the sector ...

Nifty Pharma took a beating on Friday declining over four per cent, after Donald Trump hinted at a separate tariff for ...

US President Donald Trump has imposed a country-level tariff of 27 per cent on exports from India as part of his ‘Liberation ...

Pharma stocks plummet as Trump threatens tariffs, impacting US-dependent companies and leading to market volatility.

The Trump administration's decision to exempt tariffs on Indian pharma imports brings relief to a $9 billion-plus US export ...

India emerges stronger in the US-India reciprocal tariffs scenario, negotiating favorable trade agreements and protecting ...